eglumetad has been researched along with Hyperactivity, Motor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aitta-Aho, T; Korpi, ER; Linden, AM; Maksimovic, M; Procaccini, C | 1 |
| Bannerman, DM; Barkus, C; Boerner, T; Bygrave, AM; Chen, J; Fernando, A; Gilmour, G; Harrison, PJ; Jackson, S; Sanderson, DJ; Seeburg, PH; Sprengel, R | 1 |
2 other study(ies) available for eglumetad and Hyperactivity, Motor
| Article | Year |
|---|---|
Reversal of novelty-induced hyperlocomotion and hippocampal c-Fos expression in GluA1 knockout male mice by the mGluR2/3 agonist LY354740.
Topics: Analysis of Variance; Animals; Bridged Bicyclo Compounds; Environment; Female; Genes, fos; Genotype; Hippocampus; Hyperkinesis; Immunohistochemistry; Male; Mice; Mice, Knockout; Motor Activity; Proto-Oncogene Proteins c-fos; Receptors, AMPA; Receptors, Metabotropic Glutamate; Sex Characteristics | 2013 |
The group II metabotropic glutamate receptor agonist LY354740 and the D2 receptor antagonist haloperidol reduce locomotor hyperactivity but fail to rescue spatial working memory in GluA1 knockout mice.
Topics: Animals; Bridged Bicyclo Compounds; Dopamine Antagonists; Excitatory Amino Acid Agonists; Female; Haloperidol; Hyperkinesis; Locomotion; Male; Memory, Short-Term; Mice; Mice, Inbred C57BL; Receptors, AMPA | 2017 |